{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:26:36Z","timestamp":1783077996336,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.abrep.2026.100691","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:33:21Z","timestamp":1774600401000},"page":"100691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8054-6911","authenticated-orcid":false,"given":"Pouya","family":"Azar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7473-1617","authenticated-orcid":false,"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7520-9453","authenticated-orcid":false,"given":"Jade","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Budd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-9123","authenticated-orcid":false,"given":"Kaitlyn","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-8248","authenticated-orcid":false,"given":"Jacky T.P.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-9405","authenticated-orcid":false,"given":"Anthony","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.abrep.2026.100691_b0005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/j.pain.0000000000003529","article-title":"Standardizing research methods for opioid dose comparison: The NIH HEAL morphine milligram equivalent calculator","volume":"166","author":"Adams","year":"2025","journal-title":"Pain"},{"key":"10.1016\/j.abrep.2026.100691_b0010","doi-asserted-by":"crossref","unstructured":"Aromataris, E., Lockwood, C., Porritt, K., Pilla, B., Jordan, Z., & editors. (2024). JBI Manual for Evidence Synthesis. JBI. https:\/\/synthesismanual.jbi.global.Doi: 10.46658\/JBIMES-24-01.","DOI":"10.46658\/JBIMES-24-01"},{"key":"10.1016\/j.abrep.2026.100691_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/ajad.70011","article-title":"Case series: Symptom-inhibited fentanyl induction (SIFI) onto treatment-dose opioid agonist therapy in a community setting","author":"Azar","year":"2025","journal-title":"The American Journal on Addictions"},{"issue":"8","key":"10.1016\/j.abrep.2026.100691_b0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/ajad.12809","article-title":"Methadone to buprenorphine\/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting\u2014Azar method","volume":"27","author":"Azar","year":"2018","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.abrep.2026.100691_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13722-022-00305-6","article-title":"Case report: Acute care management of severe opioid withdrawal with IV fentanyl","volume":"17","author":"Azar","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.abrep.2026.100691_b0030","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.4102\/phcfm.v14i1.3386","article-title":"Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting","volume":"14","author":"Bhoora","year":"2022","journal-title":"African Journal of Primary Health Care & Family Medicine"},{"issue":"2","key":"10.1016\/j.abrep.2026.100691_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0000000000000713","article-title":"Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series","volume":"15","author":"Brar","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.abrep.2026.100691_b0040","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1097\/ADM.0000000000000623","article-title":"Transition from Methadone to Buprenorphine using a Short-acting Agonist Bridge in the Inpatient setting: A Case Study","volume":"14","author":"Callan","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajp.2010.08.005","article-title":"Tramadol versus clonidine in management of heroin withdrawl","volume":"3","author":"Chattopadhyay","year":"2010","journal-title":"Asian Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0050","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"Edinoff","year":"2021","journal-title":"Anesthesiology and Pain Medicine"},{"issue":"1","key":"10.1016\/j.abrep.2026.100691_b0055","doi-asserted-by":"crossref","first-page":"e4753","DOI":"10.1002\/ejp.4753","article-title":"Chronic pain among primary fentanyl users: The concept of self-medication","volume":"29","author":"Kim","year":"2025","journal-title":"European Journal of Pain (London, England)"},{"issue":"1","key":"10.1016\/j.abrep.2026.100691_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/JCP.0b013e318160f827","article-title":"Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol","volume":"28","author":"Kirchheiner","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.abrep.2026.100691_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/M21-3968","article-title":"Treating opioid withdrawal in the hospital: a role for short-acting opioids","volume":"175","author":"Kleinman","year":"2022","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.abrep.2026.100691_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.11389","article-title":"Opioid Coprescription through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt","volume":"7","author":"Min","year":"2024","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.abrep.2026.100691_b0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","article-title":"A pragmatic view on pragmatic trials","volume":"13","author":"Patsopoulos","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"5","key":"10.1016\/j.abrep.2026.100691_b0080","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.abrep.2026.100691_b0090","doi-asserted-by":"crossref","unstructured":"Roy, P. (2024). Scheduled, short-acting, full agonist opioids reduces rates of in-hospital illicit opioid use and overdose. https:\/\/www.lisbonaddictions.eu\/presentations\/scheduled-short-acting-full-agonist-opioids-reduces-rates-hospital-illicit-opioid-use.","DOI":"10.1016\/j.drugalcdep.2024.112136"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0310057X0002800403","article-title":"Tramadol\u2014Present and future","volume":"28","author":"Shipton","year":"2000","journal-title":"Anaesthesia and Intensive Care"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Substance Abuse"},{"issue":"6","key":"10.1016\/j.abrep.2026.100691_b0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/10826084.2024.2306221","article-title":"Characterizing Opioid Withdrawal Experiences and Consequences among a Community Sample of people who Use Opioids","volume":"59","author":"Simpson","year":"2024","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.abrep.2026.100691_b0110","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-024-09321-5","article-title":"Treatment of Inpatient Opioid Withdrawal with Short-Acting Full Agonist Opioids at a Safety-Net Hospital","author":"Steiner","year":"2025","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v22n04_02","article-title":"Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study","volume":"22","author":"Tamaskar","year":"2004","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1016\/j.abrep.2026.100691_b0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamainternmed.2021.8111","article-title":"Short-Acting Opioids for Hospitalized patients with Opioid Use Disorder","volume":"182","author":"Thakrar","year":"2022","journal-title":"JAMA Internal Medicine"},{"issue":"9","key":"10.1016\/j.abrep.2026.100691_b0125","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/add.15893","article-title":"Opioid withdrawal management in the fentanyl era","volume":"117","author":"Thakrar","year":"2022","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.abrep.2026.100691_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13722-023-00368-z","article-title":"Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder","volume":"18","author":"Thakrar","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.abrep.2026.100691_b0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/10550490500528712","article-title":"Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study","volume":"15","author":"Threlkeld","year":"2006","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.abrep.2026.100691_b0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ADM.0000000000001498","article-title":"Intravenous fentanyl for symptom management in hospitalized patients with refractory opioid withdrawal: a retrospective cohort study","volume":"19","author":"Zazoulina","year":"2025","journal-title":"Journal of Addiction Medicine"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:08:15Z","timestamp":1783076895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853226000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S2352853226000271"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100691","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100691"}}